Phenylhomophthalimide-type NOS inhibitors derived from thalidomide

Tomomi Noguchi, Hiroko Sano, Rumiko Shimazawa, Aya Tanatani, Hiroyuki Miyachi, Yuichi Hashimoto

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Thalidomide shows moderate inhibitory activity toward neuronal nitric oxide synthase (nNOS) and inducible NOS (iNOS), but not toward endothelial NOS (eNOS). Structural development studies of thalidomide yielded novel phenylhomophthalimide-type NOS inhibitors with enhanced activity and different subtype selectivity.

Original languageEnglish
Pages (from-to)4141-4145
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume14
Issue number16
DOIs
Publication statusPublished - Aug 16 2004
Externally publishedYes

Fingerprint

Thalidomide
Nitric Oxide Synthase Type I
Phenylhomophthalimide

Keywords

  • NOS inhibitors
  • Structural development
  • Thalidomide

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Noguchi, T., Sano, H., Shimazawa, R., Tanatani, A., Miyachi, H., & Hashimoto, Y. (2004). Phenylhomophthalimide-type NOS inhibitors derived from thalidomide. Bioorganic and Medicinal Chemistry Letters, 14(16), 4141-4145. https://doi.org/10.1016/j.bmcl.2004.06.026

Phenylhomophthalimide-type NOS inhibitors derived from thalidomide. / Noguchi, Tomomi; Sano, Hiroko; Shimazawa, Rumiko; Tanatani, Aya; Miyachi, Hiroyuki; Hashimoto, Yuichi.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 14, No. 16, 16.08.2004, p. 4141-4145.

Research output: Contribution to journalArticle

Noguchi, T, Sano, H, Shimazawa, R, Tanatani, A, Miyachi, H & Hashimoto, Y 2004, 'Phenylhomophthalimide-type NOS inhibitors derived from thalidomide', Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 16, pp. 4141-4145. https://doi.org/10.1016/j.bmcl.2004.06.026
Noguchi T, Sano H, Shimazawa R, Tanatani A, Miyachi H, Hashimoto Y. Phenylhomophthalimide-type NOS inhibitors derived from thalidomide. Bioorganic and Medicinal Chemistry Letters. 2004 Aug 16;14(16):4141-4145. https://doi.org/10.1016/j.bmcl.2004.06.026
Noguchi, Tomomi ; Sano, Hiroko ; Shimazawa, Rumiko ; Tanatani, Aya ; Miyachi, Hiroyuki ; Hashimoto, Yuichi. / Phenylhomophthalimide-type NOS inhibitors derived from thalidomide. In: Bioorganic and Medicinal Chemistry Letters. 2004 ; Vol. 14, No. 16. pp. 4141-4145.
@article{e539f71568b0440cbf861f2b2b8e06b2,
title = "Phenylhomophthalimide-type NOS inhibitors derived from thalidomide",
abstract = "Thalidomide shows moderate inhibitory activity toward neuronal nitric oxide synthase (nNOS) and inducible NOS (iNOS), but not toward endothelial NOS (eNOS). Structural development studies of thalidomide yielded novel phenylhomophthalimide-type NOS inhibitors with enhanced activity and different subtype selectivity.",
keywords = "NOS inhibitors, Structural development, Thalidomide",
author = "Tomomi Noguchi and Hiroko Sano and Rumiko Shimazawa and Aya Tanatani and Hiroyuki Miyachi and Yuichi Hashimoto",
year = "2004",
month = "8",
day = "16",
doi = "10.1016/j.bmcl.2004.06.026",
language = "English",
volume = "14",
pages = "4141--4145",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "16",

}

TY - JOUR

T1 - Phenylhomophthalimide-type NOS inhibitors derived from thalidomide

AU - Noguchi, Tomomi

AU - Sano, Hiroko

AU - Shimazawa, Rumiko

AU - Tanatani, Aya

AU - Miyachi, Hiroyuki

AU - Hashimoto, Yuichi

PY - 2004/8/16

Y1 - 2004/8/16

N2 - Thalidomide shows moderate inhibitory activity toward neuronal nitric oxide synthase (nNOS) and inducible NOS (iNOS), but not toward endothelial NOS (eNOS). Structural development studies of thalidomide yielded novel phenylhomophthalimide-type NOS inhibitors with enhanced activity and different subtype selectivity.

AB - Thalidomide shows moderate inhibitory activity toward neuronal nitric oxide synthase (nNOS) and inducible NOS (iNOS), but not toward endothelial NOS (eNOS). Structural development studies of thalidomide yielded novel phenylhomophthalimide-type NOS inhibitors with enhanced activity and different subtype selectivity.

KW - NOS inhibitors

KW - Structural development

KW - Thalidomide

UR - http://www.scopus.com/inward/record.url?scp=3142666123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142666123&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2004.06.026

DO - 10.1016/j.bmcl.2004.06.026

M3 - Article

VL - 14

SP - 4141

EP - 4145

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 16

ER -